Structures by: Padrón J. M.
Total: 19
C27H21CL2N5O3
C27H21CL2N5O3
RSC Advances (2020) 10, 33 19600-19609
a=9.6991(4)Å b=15.1736(7)Å c=18.5825(9)Å
α=90° β=101.750(2)° γ=90°
C29H27N5O5
C29H27N5O5
RSC Advances (2020) 10, 33 19600-19609
a=12.2814(14)Å b=12.4871(16)Å c=16.249(2)Å
α=90° β=90° γ=90°
C18H12BRN5O2
C18H12BRN5O2
RSC Advances (2020) 10, 33 19600-19609
a=10.1063(13)Å b=10.6214(12)Å c=12.8286(16)Å
α=94.851(4)° β=97.256(4)° γ=111.253(3)°
(5aS,12bS)-12-chloro-2,3-dimethoxy-4b,5,5a,12b,14, 15-hexahydro-6H-benzo[5',6']pyrrolizino[2',1':4,5]pyrrolo[2,1-a]isoquinoline
C23H23ClN2O2
New J. Chem. (2015) 39, 4 2657
a=13.9521(10)Å b=6.6102(4)Å c=21.9770(13)Å
α=90.00° β=106.352(7)° γ=90.00°
Ethyl(2R,3aR,10bR)-1-benzyl-10-chloro-1,2,3,3a,4,10b-hexadydropyrrolo- [2'3':3,4]pyrrolo[1,2-a]indole-2-carboxylate
C23H23ClN2O2
New J. Chem. (2015) 39, 4 2657
a=9.2721(7)Å b=10.3272(6)Å c=10.7817(7)Å
α=81.614(5)° β=81.335(6)° γ=89.456(5)°
C21H31NO14S
C21H31NO14S
New J. Chem. (2017) 41, 8 3154
a=7.47001(14)Å b=17.3307(3)Å c=10.39519(18)Å
α=90° β=102.8901(18)° γ=90°
C24H27NO12S
C24H27NO12S
New J. Chem. (2017) 41, 8 3154
a=7.50613(16)Å b=14.4909(4)Å c=12.0626(3)Å
α=90° β=96.839(2)° γ=90°
C14H26Cl2N2O3PtS2
C14H26Cl2N2O3PtS2
MedChemComm (2011) 2, 8 789
a=7.9973(4)Å b=10.8873(6)Å c=11.5879(6)Å
α=95.196(3)° β=98.091(3)° γ=90.511(3)°
C48H51Cl2CoN3P3Ru,CF3O3S,0.25(O)
C48H51Cl2CoN3P3Ru,CF3O3S,0.25(O)
Dalton Trans. (2017)
a=11.1351(8)Å b=20.8269(15)Å c=22.1074(16)Å
α=106.3010(10)° β=93.3240(10)° γ=94.3000(10)°
C14H21Cl2FeNOPtS
C14H21Cl2FeNOPtS
Dalton transactions (Cambridge, England : 2003) (2012) 41, 2 432-441
a=13.1200(12)Å b=11.3110(10)Å c=11.8689(10)Å
α=90.00° β=97.208(5)° γ=90.00°
C30H36Cl3N3NiP2Ru
C30H36Cl3N3NiP2Ru
Dalton transactions (Cambridge, England : 2003) (2013) 42, 31 11212-11219
a=14.8944(9)Å b=9.4708(6)Å c=22.5306(14)Å
α=90.00° β=102.3250(10)° γ=90.00°
C30H36Cl3N3P2RuZn
C30H36Cl3N3P2RuZn
Dalton transactions (Cambridge, England : 2003) (2013) 42, 31 11212-11219
a=14.847(4)Å b=9.499(2)Å c=22.587(6)Å
α=90.00° β=102.151(6)° γ=90.00°
C11H10Cl2INO2PtS
C11H10Cl2INO2PtS
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13343-13348
a=7.2336(4)Å b=20.5641(10)Å c=20.2197(10)Å
α=90.00° β=92.9860(10)° γ=90.00°
C23H29FeN3
C23H29FeN3
Organometallics (2015) 34, 22 5407
a=37.239(3)Å b=37.239(3)Å c=8.0789(7)Å
α=90.00° β=90.00° γ=120.00°
C19H31Cl2FeN3OPtS
C19H31Cl2FeN3OPtS
Organometallics (2015) 34, 22 5407
a=9.3472(4)Å b=19.7677(6)Å c=25.5026(10)Å
α=90.00° β=90.00° γ=90.00°
D30F1
C23H29ClFeN3Pt0.5
Organometallics (2015) 34, 22 5407
a=11.8436(3)Å b=13.4194(4)Å c=28.6467(8)Å
α=90° β=90° γ=90°
D30C2F1
C25H34.5Cl2FeN3OPtS
Organometallics (2015) 34, 22 5407
a=14.5743(2)Å b=25.5911(4)Å c=15.7828(2)Å
α=90° β=91.2000(10)° γ=90°
GuanidinaFc
C17H25FeN3
Organometallics (2015) 34, 22 5407
a=15.5220(10)Å b=11.7101(7)Å c=9.2705(6)Å
α=90° β=93.101(3)° γ=90°
C48H52N3P3Ru,2(CF3O3S)
C48H52N3P3Ru,2(CF3O3S)
Inorganic chemistry (2016) 55, 16 7820-7822
a=11.2838(2)Å b=15.0822(3)Å c=30.4789(6)Å
α=90° β=98.7722(9)° γ=90°